Individual ingredients have published research, but no OTC finished product has been shown in a peer-reviewed trial to replicate the 7-24% body weight loss that prescription GLP-1 receptor agonists produce
Some patients report blurred vision early in treatment
Additionally, involve friends and family members in your weight loss goals
Activities that previously caused shortness of breath or fatigue become easier
GLP-1 agonists, such as liraglutide and semaglutide, are increasingly used in medical weight loss due to their ability to mimic the natural hormone glucagon-like peptide-1, which is, for the most part, responsible for regulating appetite and food intake
Brand names: Mounjaro (diabetes), Zepbound (obesity)